Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component C: Clinical Core
$2,651,134N01FY2024AINIH
University Of Maryland Baltimore, Baltimore MD
Investigators
Abstract
To design, implement and manage ethical and statistically sound clinical trials and human challenge studies for influenza vaccines, vaccine components and delivery systems developed by the NIAID Collaborative Influenza Vaccine Innovation Centers. Current efforts include Phase I and Phase II clinical trials.
View original record on NIH RePORTER →